✦ LIBER ✦

A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer

✍ Scribed by Kelly, R. J.; Draper, D.; Chen, C. C.; Robey, R. W.; Figg, W. D.; Piekarz, R. L.; Chen, X.; Gardner, E. R.; Balis, F. M.; Venkatesan, A. M.; Steinberg, S. M.; Fojo, T.; Bates, S. E.

Book ID: 126990190
Publisher: American Association for Cancer Research
Year: 2010
Tongue: English
Weight: 583 KB
Volume: 17
Category: Article
ISSN: 1078-0432
DOI: 10.1158/1078-0432.ccr-10-1725

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase 1 and pharmacodynamic study of d

A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer

✍ Fang Fang; Curt Balch; Jeanne Schilder; Timothy Breen; Shu Zhang; Changyu Shen; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 412 KB 👁 2 views

## Abstract ## BACKGROUND: Aberrant DNA methylation is a hallmark of cancer, and DNA methyltransferase inhibitors have demonstrated clinical efficacy in hematologic malignancies. On the basis of preclinical studies indicating that hypomethylating agents can reverse platinum resistance in ovarian c

A phase 2 study of cetuximab in combinat

A phase 2 study of cetuximab in combination with docetaxel in chemotherapy-refractory/resistant patients with advanced nonsmall cell lung cancer

✍ Edward S. Kim; Ann M. Mauer; William N. William Jr; Hai T. Tran; Diane Liu; Jack 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB 👁 2 views

A phase II study of docetaxel and vinore

A phase II study of docetaxel and vinorelbine combination chemotherapy in patients with advanced non-small cell lung cancer

✍ J Bennouna; A Monnier; A Rivière; B Milleron; E Lemarie; V Trillet-Lenoir; K Sou 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 97 KB

A multicenter phase II study of the comb

A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancer

✍ Agelaki, Sofia; Veslemes, Marinos; Syrigos, Kostas; Palamidas, Filippos; Polyzos 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Cetuximab in combination with carboplati

Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer : A multicenter phase 2 study

✍ Chandra P. Belani; Marshall T. Schreeder; Ronald G. Steis; Richard A. Guidice; T 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

A Phase I study of infusional vinblastin

A Phase I study of infusional vinblastine in combination with the p-glycoprotein antagonist PSC 833 (valspodar)

✍ Susan Bates; Min Kang; Beverly Meadows; Susan Bakke; Peter Choyke; Maria Merino; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## BACKGROUND. PSC 833 is a second-generation P-glycoprotein (Pgp) antagonist developed to reverse multidrug resistance (MDR). The authors conducted a Phase I study of orally administered PSC 833 in combination with vinblastine administered as a 5-day continuous infusion. ## METHODS. Seventy-ni